Cannabis Science Adds Two Industry Heavyweights to their Scientific Board

Cannabis Science has released two Press Releases recently to announce significant additions to their Scientific Advisory Board:

Cannabis Science Appoints Former GlaxoSmithKline Global Director of HIV Research Dorothy Bray, Ph.D., to Scientific Advisory Board Focusing on CS-TATI-1 and Other Emerging Scientific Investigations


“Dr. Bray’s extensive experience in the field of HIV drug development will compliment Cannabis Sciences’ prestigious Scientific Advisory Board as the company embarks on the research and development of a phytocannabinoid based HIV TAT inhibitor. Dr. Bray has significant expertise in clinical development and market positioning for novel drugs.

Read More


Dr. Roscoe M. Moore Jr., U.S. Assistant Surgeon General (Retired), Appointed to Cannabis Science Scientific Advisory Board


“We are honored and excited that Dr. Roscoe M. Moore, Jr. is joining the Cannabis Science Scientific Advisory Board as the company enters into further clinical development of a wide range of commercial clinical investigations. His experience and knowledge in the medical field and his background within the FDA and US Public Health Services will be a tremendous asset to Cannabis Science. In addition to overseeing the development of CS-TATI-1, he will assist in our path towards human studies for HIV drug resistance and catabolic cachexia,” commented Dr Melamede. “Dr. Moore’s decision to join Cannabis Science’s Scientific Advisory Board emphasizes the potential of phytocannabinod antiviral activity and our strong research and development efforts.”

Read More


Could this mean we’re getting closer to FDA Approval for a Cannabis Medicine? Cannabis Science is moving forward in the most professional way possible by enlisting support and guidance by distinguished doctors and retired high-level government employees. Then again, drug companies have a lot to lose if Cannabis is marketed to the masses and successfully treats and cures a plethora of disease because a plant cannot be patented.

I see signs of hope that Cannabis is being embraced by the mainstream, however, I wouldn’t wait for Big Pharma and the FDA to catch on if I were sick. I’d take immediate action for myself. Fortunately, I live in California, where it’s legal to use Cannabis. I pray that the world is given more access to this miraculous plant.

Oil Pulling

I’ve been researching oil pulling as an effective morning regimen for increased oral health, but I’ve found other research and anecdotes that support it as a cure-all, from diabetes to heart health to cancer (if used over a long period of time)… So my query is: could cannabis oil pulling add another dimension to the Ayurvedic tradition of oil pulling? And is there a history of cannabis oil pulling? I did some light research and couldn’t find evidence of cannabis oil pulling. I’ll report back if I find more. Feel free to share if you’ve heard about it or tried it.

On another note, sorry I haven’t been posting much. My laptop broke and it’s difficult to write on an iPhone. I’ll try to write more.

Cannabis Science Shows Evidence of Cancer Cure

In a recent News Release on the website, Dr. Robert Melamede, Ph.D. writes:

Every vertebrate, from the time of conception till the time of death, literally has all body systems homeostatically regulated by endocannabinoids (marijuana-like compounds produced by the body). Illnesses are biochemical imbalances, failures of homeostasis. By being alive, all organisms suffer from the common biochemical imbalances that underlie  aging and all age-related illness, including autoimmune, cognitive, cardiovascular diseases, as well as cancers.

Over 600 peer reviewed articles show that numerous cancer types (lung, breast, prostate, glioma, thyroid, leukemia, lymphoma, basil cell carcinoma, melanoma, etc) are killed by
cannabinoids in tissue culture and animal studies. Furthermore, cannabinoids inhibit the biochemical pathways involved in metastasis and drug resistance. The question that naturally arises is “Why is a plant that inhibits aging, kills cancers, and whose activity is found in mother’s milk illegal?”

Because federal and state governments have failed
to implement marijuana policies that are reflective
of modern scientific knowledge and thousands of
years of medical history, the people have demanded,
and gained access to this miraculous medicine
through direct vote with the initiative process. In
effect, marijuana clinical efforts are now in the hands
of the people and the medical marijuana community.
This poster provides dramatic photographic
evidence of cannabis extracts curing basal-cell
carcinoma via it’s topical application.

To read more, and to see the dramatic evidence … (click on the blue link to your left). It’s in the photos!

Basal-Cell Carcinoma is a serious cancer, with many not-so-great treatment options that involve freezing it off, cutting it out, chemotherapy, radiation, synthetic pills, etc. In many cases, people are left with disfigurement as a result of the cancer AND treatment. If Medicinal Cannabis was a widespread therapy, approved by insurance companies, and prescribed by doctors, wouldn’t suffering cancer patients be happy at a chance to mitigate disfigurement and avoid therapies that cause more suffering, more pain and additional damage to surrounding tissues and organs? The more people learn about cannabis medicine, the more they’ll demand it, in all 50 States.

The Cannabinoid Healing Chart, Sativex and Cannabis Science

tikidood over at shared an interesting chart, Titled: What Ails You, on the message boards. I really must recommend the community forum at; they’re a helpful bunch and really open about sharing wisdom.

This could really help a patient when choosing a strain that’s been lab-tested, or for someone like me, who makes medicine for myself and my dad. I will continue to research this, any insights the community at large wants to share are welcome here.

CBD aka Cannabidiol

“Cannabidiol (CBD) is a cannabinoid found in Cannabis. It is a major constituent of the plant, representing up to 40% in its extracts.[2]

It has displayed sedative effects in animal tests.[3] Some research, however, indicates that CBD can increase alertness.[4] It may decrease the rate of THC clearance from the body, perhaps by interfering with the metabolism of THC in the liver.

Medically, it has been shown to relieve convulsioninflammationanxiety, and nausea, as well as inhibit cancer cell growth.[5] Recent studies have shown cannabidiol to be as effective as atypical antipsychotics in treating schizophrenia.[6] Studies have also shown that it may relieve symptoms of dystonia.[7][8]

In November 2007, it was reported that CBD reduces growth of aggressive human breast cancer cells in vitro and reduces their invasiveness.

A 2008 study published in the British Journal of Psychiatry showed significant differences in Oxford-Liverpool Inventory of Feelings and Experiences scores between three groups: The first consisted of non-cannabis users, the second consisted of users with Δ9-THC detected, and the third consisted of users with both Δ9-THC and CBD detected. The Δ9-THC only group scored significantly higher for unusual experiences than the Δ9-THC and CBD group, whereas the Δ9-THC and CBD group had significantly lower introvertive anhedonia scores than the Δ9-THC only group and non-cannabis user group. This research indicates that CBD acts as an anti-psychotic and may counteract the potential effects of THC on individuals with latent schizophrenia.[9] “


CBG aka Cannabigerol

Cannabigerol (CBG) is a non-psychoactive cannabinoid found in the Cannabis genus of plants. Cannabigerol is found in higher concentrations in hemp rather than in varieties of Cannabis with high THC content (the kind used as a drug).

Cannabigerol has been found to act as a high affinity α2-adrenergic receptor agonist, moderate affinity 5-HT1A receptor antagonist, and low affinity CB1 receptor antagonist.[1] It also binds to the CB2 receptor, but whether it acts as an agonist or antagonist at this site is unknown.[1]

Cannabigerol has been shown to relieve intraoccular pressure, which may be of benefit in the treatment of glaucoma.[2][3]


CBN aka Cannabinol

Cannabinol (CBN) is the primary product of THC degradation, and there is usually little of it in a fresh plant. CBN content increases as THC degrades in storage, and with exposure to light and air. It is only mildly psychoactive. Its affinity to the CB2 receptor is higher than for the CB1 receptor.[24]


Tetrahydrocannabivarin aka THCv

Tetrahydrocannabivarin (THCVTHV) is a homologue of tetrahydrocannabinol (THC) having a propyl (3-carbon) side chain. This terpeno-phenolic compound is found naturally in Cannabis, sometimes in significant amounts. The psychoactive effects of THCV in Cannabis preparations are not well characterized.

Plants with elevated levels of propyl cannabinoids (including THCV) have been found in populations of Cannabis sativa L. ssp. indica (=Cannabis indica Lam.) from China, IndiaNepal, Thailand, Afghanistan, and Pakistan, as well as southern and western Africa. THCV levels up to 53.7% of total cannabinoids have been reported. [1] [2]

THCV has been shown to be a CB1 receptor antagonist, i.e. it blocks the effects of THC.[3]


SATIVEX, GW Pharma’s Moneymaker?

Sativex, currently going through the later trials with the FDA, is about to set a precedent if their “drug” is approved for the U.S. Market. Why?

1) Their product is not synthetic. It’s a proprietary formulation made from natural cannabis plants, not synthetics like Marinol. Sativex, if approved, will be the first phytocannabinoid drug approved in the U.S. ever! This is groundbreaking.

2) Ok, so why is that important? Cannabis is currently Schedule 1, and regulated by the Federal Government like it has no medicinal uses. Even though Marinol is made from synthetic THC, and legal for prescription use, cannabis is illegal in the eyes of the government. “We don’t want you to be able to grow your medicine, buy synthetic!” Meanwhile, cocaine and opiates are Schedule 2, because they have medical uses. Does this make sense? Heck no.

So, if the FDA approves Sativex, it will be the third instance (that I can think of) of a Federal Agency disagreeing openly with the DEA and DOJ. The first instance being when a federal judge approved cannabis for medicinal consumption in 1976 (our Bicentennial, of all years). The University of Mississippi has been sending the remaining patients cannabis joints to this day. The second instance was the the Department of Health and Human Services patent for marijuana/cannabinoids. So, the government is banning cannabis but at the same time, gearing up to profit and/or protect it as intellectual property? I don’t understand their logic or intentions. Do you? As an American, it’s our right and duty to question our government, by the people – for the people.

Please allow me to share some of my research with you. I have cited my sources and urge you to explore on your own.

When Robert Randall took on the Federal Government:

“The origins of the Compassionate Investigational New Drug Study program began in 1976 after Robert Randall brought a lawsuit (Randall v. U.S) against the Food and Drug Administration, the Drug Enforcement Administration, the National Institute on Drug Abuse, the Department of Justice, and the Department of Health, Education & Welfare. Randall, afflicted with glaucoma, had successfully used the Common Law doctrine of necessity to argue against charges of marijuana cultivation because it was deemed a medical necessity (U.S. v. Randall). On November 24, 1976, federal Judge James Washington ruled:

“While blindness was shown by competent medical testimony to be the otherwise inevitable result of the defendant’s disease, no adverse effects from the smoking of marijuana have been demonstrated. Medical evidence suggests that the medical prohibition is not well-founded.”

The criminal charges against Randall were dropped, and following a petition (May 1976) filed by Randall, federal agencies began providing him with FDA-approved access to government supplies of medical marijuana, becoming the first American to receive marijuana for the treatment of a medical disorder. Randall went public with his victory and shortly after the government tried to prevent his legal access to marijuana. This led to the 1978 lawsuit where Randall was represented pro bono publico by law firm Steptoe & Johnson. Twenty-four hours after filing the suit, the federal agencies requested an out-of-court settlement which resulted in Randall gaining prescriptive access to marijuana through a federal pharmacy near his home.

The settlement in Randall v. U.S. became the legal basis for the FDA’s Compassionate IND program. Initially only available to patients afflicted by marijuana-responsive disorders and orphan drugs, the concept was expanded to include HIV-positive patients in the mid-1980s. Due to the growing number of AIDS patients throughout the late 1980s and the resulting numbers of patients who joined the Compassionate IND program, the George H. W. Bush administration closed the program down in 1992. At its peak, the program had thirty active patients.

Clinton A. Werner, author of “Medical Marijuana and the AIDS Crisis”, says that the closure of the government program during the height of the AIDS epidemic led directly to the formation of the medical cannabis movement in the United States, a movement which initially sought to provide cannabis for treating anorexia and wasting syndrome in AIDS patients.[2]



Federal Funding for Cannabis – And It’s Still Schedule 1?

Federal Funding, American tax dollars, for medical marijuana and marijuana research has been going on as early as 1968, yet it’s 2012 and a MD still can’t prescribe cannabis when paper after paper, and study after study, along with mountains of anecdotal evidence, prove beyond a reasonable doubt that cannabis can be used for healing a wide range of illnesses.

“Since 1968, the school operates the only legal marijuana farm and production facility in the United States. The National Institute on Drug Abuse (NIDA) contracts to the university the production of cannabis for the use in approved research studies on the plant as well as for distribution to the seven surviving medical cannabis patients grandfathered into the Compassionate Investigational New Drug program(established in 1978 and canceled in 1991).[38]


If Sativex is approved in the United States for prescription use, it will be a landmark case. For the first time, a phytocannabinoid medicine will be covered by an insurance plan. Can you imagine! How many patients keep their cannabis treatment plan in the dark? How many American Citizens could benefit by re-education about the plant, it’s wonderful diversity and healing nature? It’s time we grow up when it comes to cannabis. It’s limitless if we allow ourselves to re-examine our culture of synthetic medicine and move back toward our roots in a natural lifestyle. The culture of convenience is killing us. If you treat the symptoms, but not the cause, you will continue to suffer. It’s that simple. Listen to your own intuition; follow your own path to the Light.

P.S. I hope that if Sativex is approved, Cannabis Science (OTC: CBIS) will have their application with the FDA expedited (or even better: approved in tandem), because why should a British company be able to get first to market when an American company is just as able. I’m not a Nationalist (I am horrified by history’s skeleton of the notion), but the economics of the situation, and the local supply, should be tilted in America’s favor. We have the capacity, know-how and passion to produce it. Homegrown, and the tax dollars will help the United States get out of debt. Everyone wins.

Disclaimer: I do own shares in Cannabis Science (OTC: CBIS). However, my intentions are pure. I want Cannabis completely legalized in the United States and I want American entrepreneurs to reap the rewards. Not big pharma, not the tobacco companies, not the alcohol companies… because they will just pervert it, grow it en masse with all kinds of chemicals and ruin the medicinal and nutritional benefits of the hemp plant with their cold, calculating economics. Monsanto reportedly has ties with GW Pharmaceuticals, although I haven’t been able to confirm that.

Cannabis Science Announces Investigational New Drug Application with the FDA

Cannabis Science, following in the path of GW Pharmaceuticals, is beginning the process of obtaining FDA approval for their cannabis formulations via the Investigational New Drug application process.

“Cannabis Science, Inc. (OTCBB: CBIS.OB) a pioneering U.S. biotech company developing pharmaceutical cannabis (marijuana) products, is pleased to inform that the current progress and success with their numerous self-medicated cancer patients, has lead the Company to immediately begin the Investigational New Drug (IND) application process that will target cancer treatment.

Cannabis Science is currently tracking numerous cancer patients, who are self-medicating with cannabis extracts. The Company has evident success with these patients, which creates support to submit an IND application to the FDA. The prescription pharmaceutical market is the number one target market for Cannabis Science, and with having the appropriate backup for the application process, it is all very promising for the Company and cancer patients worldwide.

Cannabis Science currently has documented images for the first three apparently successful self-medicated cancer patients, and the Company is waiting for more documentation and images associated with other patients. The first patient had basal cell carcinoma (skin cancer) on her face, and after applying the topical cannabis extracts within 10 days it appeared the lesion was gone. Cannabis Science received documentation from her surgeon that she would not need to undergo any surgical procedures and was free of cancer cells. The second patient, who has basal cell carcinoma on their arm, has gotten dramatic results. Their treatment has been completed, and Cannabis Science is just waiting for a full biopsy report from the patient’s physician to inform that they are free of cancer cells. A special case, involves a third patient with severe squamous cell carcinoma on his head. His physician prior to using cannabis extracts had told this patient, that there was nothing more that could be done. Cannabis Science has gotten drastic results, along with photographed documentation of the treatment process. This patient’s treatment is still in progress, but with photographic evidence you can see the effectiveness of the cannabis-based extracts.”

Read the full News Release, Cancer Patient Success Prompts Cannabis Science To Begin FDA Investigational New Drug (IND) Application Process.

The Investigational New Drug application process with the FDA can be long and costly. Sativex, a phytocannabinoid medicine, is currently approved in Canada, Denmark, Germany, New Zealand, Spain and the U.K.; currently, it’s in the IND process in the United States. If Sativex is approved in the U.S., it will be a landmark decision because it will be legal for MDs to prescribe phytocannabinoids in the U.S. on a federal level. Currently, only synthetic cannabinoids are legal to prescribe by doctors. Under various State laws, Medical Doctor’s are legally allowed to make Medical Marijuana Recommendations, but they’re not allowed to prescribe it which is why you buy your cannabis from a dispensary or collective instead of a pharmacy.

If Sativex and/or Cannabis Science formulations are approved by the FDA, I predict that this will require that cannabis be re-scheduled from Schedule 1 to Schedule 2, at a minimum. Currently, the U.S. Federal Government contends:

“Substances in this schedule have a high potential for abuse, have no currently accepted medical use in treatment in the United States, and there is a lack of accepted safety for use of the drug or other substance under medical supervision. Some examples of substances listed in schedule I are: heroin, lysergic acid diethylamide (LSD), marijuana (cannabis), peyote, methaqualone, and 3,4-methylenedioxymethamphetamine (“ecstasy”).”

Source: Controlled Substance Schedules

However, this contradicts a newer government patent granted in 2003 to the “Assignee: United States of America as represented by the Department of Health and Human Services,” a patent on healing powers of cannabis and cannabinoids. This patent claims:

“Cannabinoids have been found to have antioxidant properties, unrelated to NMDA receptor antagonism. This new found property makes cannabinoids useful in the treatment and prophylaxis of wide variety of oxidation associated diseases, such as ischemic, age-related, inflammatory and autoimmune diseases. The cannabinoids are found to have particular application as neuroprotectants, for example in limiting neurological damage following ischemic insults, such as stroke and trauma, or in the treatment of neurodegenerative diseases, such as Alzheimer’s disease, Parkinson’s disease and HIV dementia.”

Source: Cannabinoids as antioxidants and neuroprotectants | Patent No:  US 6,630,507 B1 | Date: Oct. 7, 2003

How much longer can the U.S. Government live a lie? It’s time to accept the truth about cannabis and allow it’s wider use for the help of all human beings. It’s not about who’s right or wrong, that’s the ego getting in the way of the Light; life is too short for that nonsense. Let’s move forward.

Live in the Light of Truth!

Full Disclosure: I own shares in CBIS


Medicinal Cannabis Oil Recipes

I may update this post in the future, but for now, I’ve listed a few vague recipes for Cannabis Oils. If you want some context on the process, look over at this post and for an Update follow-up, this post.

Bliss Healing Oil – Edible/Topical


  • extra virgin olive oil
  • cannabis: variety of organically grown and properly cured cannabis for a broad cannabinoid profile
  • lysine
  • soy lecithin
  • unrefined shea butter
  • virgin cold-pressed coconut oil

Bliss Healing Oil – Topical Only


  • extra virgin olive oil
  • calamus oil**
  • cannabis: variety of organically grown and properly cured cannabis for a broad cannabinoid profile
  • calamus oil**
  • cassia oil**
  • lysine
  • myrrh oil*
  • soy lecithin
  • unrefined shea butter
  • virgin cold-pressed coconut oil

*essential oil used

**small amounts of this essential oil are used due to reported health risks at higher dosages

Uses: this oil is very powerful and can be used for medicinal purposes topically.

Tea Tree Cannabis Oil


  • cannabis: variety of organically grown and properly cured cannabis for a broad cannabinoid profile
  • lysine
  • tea tree oil*
*Tea Tree Oil should not be ingested. Be careful not to put it near your eyes.
Uses: disinfecting wounds, healing breaks in the skin, if diluted in water it can be used as a  mouthwash (do not swallow tea tree oil, it may cause diarrhea), good for acne and blemishes

Cannabis Science Reports Initial Success in Cancer Patient

Cannabis Science is reporting that one of it’s initial Cancer patients is self-medicating with their formulation and seeing success after just two weeks! This is very exciting news for Cancer patients throughout the world.

January 11, 2012  COLORADO SPRINGS, Colo.–(BUSINESS WIRE)– Cannabis Science, Inc. (OTCBB: CBIS.OB – News), a pioneering US biotech company developing pharmaceutical cannabis products, is happy to report an additional, apparently successful, self-medicated cannabis treatment for a cancer patient. This case is very graphic in nature. One of the patient’s physicians said it was the worst case of squamous cell carcinoma cancer he had ever seen, while another refused to continue tending to the patient.

Read more of the article by clicking on the link, Cannabis Science Reports Apparent Success For 3rd Self-Medicated Cancer Patient. Photos are available here. Warning: The photos are very graphic.

Another interesting Press Release on CBIS and their business’ growth potential might be interesting to my readers, Cannabis Science Entering a Potential $80bil Cancer Drugs Market. The following is an excerpt:

NEWPORT BEACH, Calif. , Jan. 10, 2012 /PRNewswire/ — On December 21, 2011 Cannabis Science, Inc. (OTCBB:CBIS.OB) reported many critical ailments of which the Company has identified as part of its ongoing mission to capture the market share. One of which is Cancer with estimated Global drug sales growth at a compounded annual rate of 12 to 15 percent, reaching $75 to $80 billion by 2012. Conservatively speaking, if the Company is able to capture only 1% (one percent) of the Cancer market, it would translate to approximately $75 (seventy five) million in that segment alone.

If these figures are on the low-end spectrum then the Company’s Earnings Guidance on December 29, 2011 could be well under-estimated since their 2012 forecasted only $6,846,000 and potentially $65,740,000 by 2014. It’s a bit early to tell if the Company is able to hit these numbers but judging from their earlier successes from recent case studies, the Company is on the right path to accomplish its goals and maybe more.

Cannabis Science went on to mention that it’s making cannabis-based medicines available to the public as rapidly as possible. The Company is taking multiple approaches to accomplishing this aim in the United States . The science of cannabinoids has exploded over the past decade, laying the scientific foundation for the many medicinal uses of this unique plant. Cannabinoids are a class of biologically active compounds produced by all vertebrates (endocannabinoids) the Cannabis plant (phytocannabinoids), and more recently patentable synthetic compounds produced by chemists. Today’s modern peer-reviewed science supports the many historical uses that were discovered over thousands of years of medicinal use by herbalists.

Full Disclosure: I own shares in CBIS.

Cannabis Science Issues 2012 Guidance

I found a great article on the 2012 Guidance for Cannabis Science here, and I’ve included an excerpt:

CBIS said that currently there are three main markets for Cannabis Science Brand formulations for distribution; FDA approved prescriptions, OTC Non-psychoactive Neutroceuticals and licensed dispensaries in legal medical marijuana states.

CBIS expects 2012 sales to be $6.84 million. The company said that its sales can potentially increase nearly ten times the forecasted 2012 sales in 2014. If CBIS manages to increase sales ten times, the company would have positive earnings of $0.02 per share in 2014.

CBIS said that is dedicated to working with the Federal, State, and Local regulatory agencies, as well as similar agencies in other countries. The company said that its forecast includes sales from both the MEDBOX strategic alliance and the revenues from its licensing fees from cannabis-extract based formulations.

Cannabis Science has also prepared a model to forecast sales upon FDA approval. This model shows average sales of $279.12 million annually. The forecast does not include any potential revenue through signature fees from a distribution agreement for Cannabis Science formulations either in the U.S. or in any international markets.

Full Disclosure, I own Cannabis Science stock. And I hope the federal government reclassifies cannabis from a schedule 1 narcotic to a schedule 2 or 3, like Colorado just requested.

Merry Christmas Dad, Here’s Some Bliss Cannabis Oil!

I made a special Bliss Cannabis Oil for my dad this Christmas and I’m really happy with the way it turned out. Skip to the end to read my observations.

Strains of Cannabis:

  • 2g of J1: Jack Herer x Skunk #1 – 100% Sativa
  • 2g of Blue Cheese: 75% Indica/25% Sativa – 18.0% THC/1.0% CBD
  • 2g of LA Confidential: 25% THC
  • 2g of Pure Agent Orange: 100% Indica
  • 3g of Pure OG: 100% Indica
  • Note: I used a variety of cannabis to create a diverse cannabinoid profile. For a larger batch, I would like to try a pound, with 16 different strains of medicinal grade cannabis. I think this would be a very effective treatment for someone fighting a serious illness.

Other Ingredients:

  • 60g of Lecithin
  • 10g of L-Lysine
  • 10oz of virgin cold-pressed coconut oil
  • 3oz of coconut cannabis oil from last batch
  • 2oz of emu oil
  • 4oz of jojoba oil
  • essential oils: bergamot, clary sage, calamus, cassia, cinnamon, lavender, myrrh


  1. Grind up all of the marijuna in a grinder, the finer it is, the better.
  2. Decarboxylate 11g of Cannabis for 25min in oven at 220F in Pyrex 10×18 dish, and cover in aluminum foil to prevent vapors from escaping.
  3. Let Pyrex cool for 20 min with oven door open and oven turned Off. Keep aluminum foil ON.
  4. Mix 30g of Lecithin and 5g of L-Lysine. Break up the granules prior for more absorption.
  5. Add Lecithin and L-Lysine mixture, spread evenly over the Decarbed Cannabis.
  6. Warm the coconut oil by spooning room temperature oil into a bowl and submerging bowl in warm water. Add the liquefied Coconut Oil and spread it evenly over cannabis/Lecithin/L-Lysine mixture.
  7. Put Pyrex dish with aluminum foil back into the oven for 50min at 220F
  8. Let cool for 50min with oven door open and oven turned Off.
  9. Place Pyrex dish on a towel on the counter-top and wait until the Pyrex has cooled down before the the next step. Caution: Pyrex can explode if going from hot to cold OR cold to hot too quickly. Exercise caution or you risk injury.
  10. Freeze for 3 hours. Keep foil On.
  11. Thaw for 1 hour on counter-top with towel. Wait until it’s liquid before proceeding with next step.
  12. Add 30g of Lecithin and 5g of L-Lysine. Try to break up the cannabis as you mix everything together.
  13. Heat at 220F for 75min
  14. Freeze overnight for 8-12 hours.
  15. Thaw for 3 hours.
  16. Strain in cheese cloth or coffee filters. There are cotton tea filters that I used in this batch that worked very well.
  17. Mix 2oz of emu oil with 4oz of jojoba oil and add into the oil.
  18. Add essential oils and mix everything together with a wooden spoon.
  19. Pour and store in a Miron glass jar.
  20. Note: This Oil is for topical use. It will not harm you if ingested in small quantities but I do not endorse that because some people may be sensitive to essential oils. If you want to eat this oil, leave out the essential oils. Trust your instincts, your body knows what’s best.


This batch of oil is strong and provides great pain relief in muscles and joints. I’ve used it on aches from hiking and working out and the pain is always gone by the next day. It’s very effective at moisturizing dry skin and put it on my face every day, as well as my lips. It adds a certain glow. I use it in small quantities applied with my fingertips and a delicate touch. I treat it with reverence in my heart because I know Bliss Cannabis Oil is medicine.

My father commented that when he used it before he golfed, that he felt a little off-balance. I can’t say for sure whether the oil was the cause because my dad’s 84 years young and suffers from blood pressure issues. But I advised him to apply the Bliss Cannabis Oil after exercise to be on the safe side. Night time is the best time to apply it, when you know you can get rest for an extended period. Healing requires sleep and healthy nutrition.

CA Medical Marijuana – New Ballot Initiative in 2012?

I read an article this morning about a lobby of medical marijuana organizations in California putting together a ballot initiative for 2012.

The article in the Mercury News, CA medical marijuana backers ready ballot measure by Lisa Leff, says:

After months of study, a coalition of medical marijuana activists led by Americans for Safe Access and a labor union that represents dispensary workers in Northern California, have proposed a 2012 ballot initiative that would create an appointed Board of Medical Marijuana Enforcement charged with overseeing businesses and nonprofits that grow, distribute, sell and test pot both in its raw state and in finished products like food items.

The article goes on to say how the board would oversee the state, and how the new regulating body will pay for itself, a very important ingredient when adding anything new to California’s broke State Government.

At the state level, the envisioned regulatory scheme would be financed through application and registration fees, as well as through a 2.5 percent retail sales tax on marijuana and pot-infused products. Most of the proceeds would go toward running the enforcement program, although any profits would be earmarked for medical marijuana research and for supporting uninsured emergency room visits in the state, the only beneficiary not directly related to the industry.

I’d have to read the ballot initiative to truly understand the scope of what they propose, but I think it’s unethical of Sacramento and Riverside city and county officials to outright ban collectives when the voters of California voted for medical marijuana back in 1996. Sick people need access; the indignity of Peter McWilliams’ death proved that point clearly. The more regulated, the more government interference (which Ron Paul supporters like me despise), however the recent federal involvement in a State’s issue is a real kick in the butt for California to assert our State rights and get medical marijuana regulated on a state level.

California, with it’s fantastic soil and growing conditions, could be what turns around California’s economy and it could also give a boost to the agricultural industry. What’s 2.5% of a $50 Billion industry? $1.25 Billion. It wouldn’t take long to get there when you consider the medicines we can make with this wonder-plant. $500 Billion isn’t so far-fetched when you consider that California currently supplies 50% of the produce for the entire United States. Think about this: what if cannabis was legalized on a federal level and California provided 50% of the cannabis in the United States. There’s an ecological upside as well, according to Marijuana, Dark Horse Savior of California Agriculture by Sam Kornell:

According to an analysis conducted by state officials, the market price for marijuana would likely drop by half or more if it were fully legalized. But they also believe the drop would be accompanied by a significant growth in the number of people buying pot — they put the figure at 40 percent.

That projection is deeply provisional, but it’s reasonable to assume that the overall market for marijuana would grow significantly were it legalized. Such growth wouldn’t be painless — many small Northern California pot economies would suddenly have to vie with lower prices and, potentially, competition from powerful agriculture corporations. And of course the “October Millionaires,” the Northern Californians who rake in cash at the end of every fall harvest, would have to develop new business models — perhaps modeled after Northern California’s rich boutique wine industry — or risk extinction.

But while fewer individuals would get rich, the industry dedicated to the cultivation and sale of marijuana would expand. That would mean more work for agricultural workers, more associated economic activity and more taxes. Of course, it would also mean more resource use. More marijuana would be grown, requiring more land, more energy and, critically, more water. And when that marijuana is harvested and sold, it would cost less. What then would separate it from any other of the state’s major cash crops, other than the fact that it’s not food, and thus unessential?

There are two answers. First, while growing outdoor pot is not especially ecologically benign, it’s far more benign than raising commodities like cattle, rice or alfalfa. Consider: Agriculture uses 80 percent of California’s developed water supply; alfalfa soaks up a full 20 percent of that. The alfalfa is used primarily to create forage for feedlot and dairy. That means that 1 gallon out of every 5 used in California goes to a crop that humans can’t eat.

People don’t make a meal of marijuana either, of course. But measured by water, marijuana barely registers on the California’s water scale. A pound of pot requires, at the outermost limit, 250 gallons to grow, which means that a large serving of it requires about a half pint of water. By contrast, an orange takes 13 gallons water, a glass of wine 32 gallons, and a hamburger 600 gallons.

Traditional pharmaceutical companies, like GW Pharmaceuticals with Sativex, see the dollar signs too. Marinol has been around for years. Let traditional farmers grow marijuana and hemp on that land and see how much money the state earns in tax revenue. Encourage California biomedical companies to research cannabis and invest resources in proving other studies, like this one showing autophagy (programmed cell death) in brain cancer cells. This is remarkable. Brain Cancer can be one of the hardest cancers to treat, and in many cases, it’s a death sentence. Cannabis has a massive amount of anecdotal evidence for treating a multitude of issues and hundreds of medical papers on the subject, but if the government and science companies put their full backing behind it, we can speed up the discovery process and really learn how to best utilize the cannabis plant and combine it with other plant-based medicines to make true wonder drugs from mother nature. We can also help shore up California’s Budget Crisis and protect our Agriculture Industry specifically, with a side benefit of offering a crop that uses less water per dollar.

I have a recipe which is based loosely on Rick Simpson’s cannabis cure oil method, as well as BadKat’s coconut cannabis oil recipe. Hat tip to the two of them for their inspiration. Send me a note if you’d like to learn more.

P.S. My guess, those emergency room visits will be free of charge for everyone IF the ballot initiative is passed in 2012. But we all know, other state services will try to get their hand in the cookie jar before that happens.

Cannabis Science is Branching Out to California

Full disclosure: I own stock in CBIS.

Cannabis Science is “pleased to announce it has entered final negotiations to bring Cannabis Science Brand of Pharmaceutical products into California.

Read more of the article, Cannabis Science Negotiates Commercialization Deal to Bring Cannabis Science Brand Formulations Immediately into the California Market.

I’m very happy they’re expanding their market. Cannabis Science is a pioneering company in the cannabis extracts market. Their products will help standardize cannabis medicine. Dr. Robert Melamede, the founder of Cannabis Science, Inc. is an expert in this field. Check out this fascinating speech he gives on the Endocannabinoid System and Cannabis Medicine.

Pat’s Legacy: Where I Buy My Orange County Cannabis

I’ve had my medical cannabis license for over two years, and in that two years, I’ve found two companies which supply the goods. The first I’d like to mention is California Patient Association. They’re located in Santa Ana, and while they’re not my go-to guys anymore, they’re still the best brick and mortar collective in Orange County. Chubbs, the owner, is one of the savviest businessmen in the MMJ field. I love their newsletters which go out Monday thru Sunday, rain or shine. Check out his brand, Nuggetry and sign up for their Daily Dank Newsletter.

Pat’s Legacy, a south Orange County delivery service, is hands down the best supplier of medical grade cannabis flowers. And did I say they deliver! John, the founder, is a compassionate man and he started the company after his brother Pat passed away from cancer. I love his customer service and his passion for medicinal cannabis. I recently picked up 3/8 of L.A. Confidential which tested at 25% THC. His medicine is strong and reasonably priced. If you call him after reading my testimonial, please let me know in the comments.

Facts About the Endocannabinoid System

Let’s start with Raphael Mechoulam, the first scientist to isolate THC, and the Doctor of Cannabinoid Chemistry.

Dr. Mechoulam, along with pharmacologist Dr. Habib Edery and colleagues, went on to isolate and elucidate the structures of most members of the cannabinoid group of compounds in the cannabis plant. Twenty-eight years after discovering THC, in 1992, Dr. Mechoulam, along with Dr. William Devane and Dr. Lumir Hanus, identified the brain’s first endogenous cannabinoid (or endocannabinoid)—the brain’s natural version of THC—which they named “anandamide,” from the Sanskrit word “ananda,” which means “eternal bliss” or “supreme joy.”

Source: New Developments in Cannabinoid-Based Medicine: An Interview with Dr. Raphael Mechoulam

Next, let’s define the Endocannabinoid System. Dustin Sulak, DO wrote a fascinating article, Introduction to the Endocannabinoid System.

The endogenous cannabinoid system, named after the plant that led to its discovery, is perhaps the most important physiologic system involved in establishing and maintaining human health. Endocannabinoids and their receptors are found throughout the body: in the brain, organs, connective tissues, glands, and immune cells. In each tissue, the cannabinoid system performs different tasks, but the goal is always the same: homeostasis, the maintenance of a stable internal environment despite fluctuations in the external environment.

Cannabinoids promote homeostasis at every level of biological life, from the sub-cellular, to the organism, and perhaps to the community and beyond. Here’s one example: autophagy, a process in which a cell sequesters part of its contents to be self-digested and recycled, is mediated by the cannabinoid system. While this process keeps normal cells alive, allowing them to maintain a balance between the synthesis, degradation, and subsequent recycling of cellular products, it has a deadly effect on malignant tumor cells, causing them to consume themselves in a programmed cellular suicide. The death of cancer cells, of course, promotes homeostasis and survival at the level of the entire organism.

Endocannabinoids and cannabinoids are also found at the intersection of the body’s various systems, allowing communication and coordination between different cell types. At the site of an injury, for example, cannabinoids can be found decreasing the release of activators and sensitizers from the injured tissue, stabilizing the nerve cell to prevent excessive firing, and calming nearby immune cells to prevent release of pro-inflammatory substances. Three different mechanisms of action on three different cell types for a single purpose: minimize the pain and damage caused by the injury.

The endocannabinoid system, with its complex actions in our immune system, nervous system, and all of the body’s organs, is literally a bridge between body and mind. By understanding this system we begin to see a mechanism that explains how states of consciousness can promote health or disease.

In addition to regulating our internal and cellular homeostasis, cannabinoids influence a person’s relationship with the external environment. Socially, the administration of cannabinoids clearly alters human behavior, often promoting sharing, humor, and creativity. By mediating neurogenesis, neuronal plasticity, and learning, cannabinoids may directly influence a person’s open-mindedness and ability to move beyond limiting patterns of thought and behavior from past situations. Reformatting these old patterns is an essential part of health in our quickly changing environment.

Next, I’d like to share this video which illustrates how Endocannabinoids work in the human body. It’s a great way to understand these concepts if you’re a visual learner.